Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US
A District Judge overturned last year's jury verdict, declaring the application of Teva's patents overly broad.
Filings
Signal: Illumina leads $15m investment in Broken String Biosciences
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Signal: Allina health will no longer bar indebted patients from care
Signal: Abortion pill restriction may drive more patients to off-label drug
Lilly’s reported net income surges 85% in Q2 2023
Gilead reports 8.45% dip in net income for Q2 2023
Pfizer announces drop in reported net income in Q2 2023
